Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.71%219.1B | 15.46%218.92B | 7.97%792.63B | 8.54%206.27B | 13.76%200.63B | 5.25%196.13B | 4.55%189.6B | 9.51%734.1B | 9.32%190.04B | 2.25%176.36B |
Cost of revenue | 8.79%29.85B | 30.52%32.07B | 2.35%104.64B | -5.07%26.75B | 17.99%25.87B | 4.68%27.44B | -5.18%24.57B | -0.78%102.24B | 9.00%28.18B | -15.30%21.93B |
Gross profit | 12.19%189.25B | 13.22%186.85B | 8.88%687.99B | 10.91%179.52B | 13.16%174.76B | 5.34%168.69B | 6.17%165.03B | 11.38%631.86B | 9.37%161.86B | 5.34%154.43B |
Operating expense | 13.01%70.23B | 15.72%72.19B | 10.19%254.54B | 13.02%66.43B | 10.30%63.58B | 7.36%62.15B | 10.04%62.38B | 13.34%230.99B | 12.41%58.78B | 11.41%57.64B |
Staff costs | 16.51%52.43B | 20.04%53.17B | 14.88%184.61B | 19.66%48.85B | 16.21%46.46B | 11.46%45B | 12.08%44.3B | 12.18%160.7B | 11.40%40.83B | 10.17%39.98B |
Selling and administrative expenses | 17.83%5.03B | 43.04%6.29B | 14.08%18.26B | 23.41%4.98B | 20.55%4.61B | 5.20%4.27B | 7.61%4.4B | 21.37%16B | 28.66%4.04B | 5.28%3.83B |
-Selling and marketing expense | 17.83%5.03B | 43.04%6.29B | 14.08%18.26B | 23.41%4.98B | 20.55%4.61B | 5.20%4.27B | 7.61%4.4B | 21.37%16B | 28.66%4.04B | 5.28%3.83B |
Depreciation and amortization | 0.56%11.8B | -6.52%11.67B | -4.84%47.22B | -9.25%11.6B | -9.40%11.41B | -4.53%11.73B | 4.38%12.48B | 15.33%49.62B | 11.80%12.78B | 17.77%12.59B |
-Depreciation | 0.56%11.8B | -6.52%11.67B | -4.84%47.22B | -9.25%11.6B | -9.40%11.41B | -4.53%11.73B | 4.38%12.48B | 15.33%49.62B | 11.80%12.78B | 17.77%12.59B |
Other operating expenses | -14.96%978M | -12.35%1.06B | -4.64%4.46B | -11.85%1B | -11.68%1.1B | -1.63%1.15B | 7.20%1.21B | 7.30%4.67B | 5.66%1.14B | 10.41%1.24B |
Operating profit | 11.71%119.02B | 11.70%114.66B | 8.13%433.45B | 9.71%113.09B | 14.86%111.18B | 4.19%106.54B | 3.95%102.65B | 10.29%400.86B | 7.71%103.08B | 2.04%96.79B |
Net non-operating interest income (expenses) | 32.32%-335M | 35.23%-331M | -6.00%-1.93B | 13.26%-471M | -12.56%-448M | -16.75%-495M | -13.30%-511M | -9.13%-1.82B | -22.85%-543M | -11.48%-398M |
Non-operating interest expense | -32.32%335M | -35.23%331M | 6.00%1.93B | -13.26%471M | 12.56%448M | 16.75%495M | 13.30%511M | 9.13%1.82B | 22.85%543M | 11.48%398M |
Net investment income | -210.72%-3.82B | -70.29%1.99B | 17,340.00%9.59B | 1,388.92%10.81B | 7.10%-11.38B | -45.50%3.45B | -1.53%6.7B | -99.06%55M | -126.91%-839M | -559.67%-12.25B |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | 0 | 42.86%-8M | ||||||||
Special income (charges) | 0 | 0 | -716.17%-8.83B | 0 | -57.53%-879M | -13M | -7.94B | -0.37%-1.08B | 42.04%-524M | -220.69%-558M |
Less:Write off | --0 | --0 | 716.17%8.83B | --0 | 57.53%879M | --13M | --7.94B | 0.37%1.08B | -42.04%524M | 220.69%558M |
Other non-operating income (expenses) | -13.41%-52.02B | -4.82%-52.13B | -7.43%-195.73B | -8.82%-51.34B | -8.21%-48.78B | 1.02%-45.87B | -14.10%-49.73B | -16.92%-182.19B | -7.93%-47.18B | -11.22%-45.08B |
Income before tax | -1.22%62.84B | 25.45%64.19B | 9.61%236.56B | 33.51%72.09B | 29.07%49.69B | 2.90%63.62B | -16.83%51.17B | 2.43%215.83B | 0.41%54B | -25.86%38.5B |
Income tax | -37.48%9.94B | 34.14%17.13B | 14.78%54B | 27.50%14.62B | 34.49%10.7B | 9.66%15.91B | -2.63%12.77B | 3.66%47.04B | -15.89%11.46B | -27.78%7.96B |
Net income | 10.87%52.9B | 22.56%47.06B | 8.16%182.57B | 35.14%57.48B | 27.66%38.99B | 0.83%47.71B | -20.67%38.4B | 2.10%168.79B | 5.94%42.53B | -25.34%30.54B |
Net income continuous operations | 10.87%52.9B | 22.56%47.06B | 8.16%182.57B | 35.14%57.48B | 27.66%38.99B | 0.83%47.71B | -20.67%38.4B | 2.10%168.79B | 5.94%42.53B | -25.34%30.54B |
Noncontrolling interests | -35M | -155.87%-100M | 693.33%1.19B | 306.82%179M | -81.60%150M | |||||
Net income attributable to the company | 10.95%52.93B | 23.40%47.16B | 7.55%181.38B | 32.81%56.29B | 27.66%38.99B | 0.83%47.71B | -20.97%38.22B | 2.51%168.64B | 7.51%42.38B | -25.26%30.54B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | -1M | -1M | 0 | 0 | 200.00%1M | 0 | 0 | 0 |
Net income attributable to common stockholders | 10.95%52.93B | 23.40%47.16B | 7.55%181.38B | 32.81%56.29B | 27.66%38.99B | 0.83%47.71B | -20.97%38.22B | 2.51%168.64B | 7.51%42.38B | -25.26%30.54B |
Gross dividend payment | ||||||||||
Basic earnings per share | 13.08%152.02 | 23.47%134.67 | 9.73%515.48 | 36.01%162.69 | 28.37%110.26 | 2.66%134.43 | -17.89%109.07 | 5.22%469.76 | 11.37%119.62 | -22.45%85.89 |
Diluted earnings per share | 13.10%151.97 | 24.64%134.62 | 9.76%515.27 | 36.04%162.64 | 28.40%110.22 | 2.68%134.37 | -18.62%108.01 | 5.28%469.47 | 11.42%119.55 | -22.40%85.84 |
Dividend per share | 0.00%45 | 0 | 0.00%110 | 0.00%65 | 0 | 0.00%45 | 0 | 0.00%110 | 0.00%65 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |